Effect Of Open And Closed System Peripheral Catheters Used In Pediatric Services
NCT ID: NCT06312215
Last Updated: 2024-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2023-05-26
2023-10-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Tubular Bandage Application on Peripheral Intravenous Catheter Usage Time and Infiltration in Children
NCT06579820
Closed Intravenous Catheter System on Catheter Success, Length of Stay and Complications
NCT05769452
Peripheral Intravenous Catheter Bundle
NCT07249255
Comparing Peripherally Inserted Central Catheters to Long Peripheral Catheters in Pediatrics
NCT05346406
A Randomized Controlled Trial to Demonstrate the Safety and Efficacy of the OptiVein IV Catheter In a Pediatric Population
NCT02265380
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Location and Characteristics of the Study:
The research data were collected from pediatric patients in the Department of Pediatric Health and Diseases at Istanbul University Istanbul Faculty of Medicine. The pediatric services within the Department include Gastrohepatology, Neurology, Nutrition and Metabolism, Cardiology, Allergy and Immunology, Nephrology, Rheumatology, Endocrinology, and Chest Diseases, comprising a total of 47 service beds.
Study Population and Sample:
The study population consisted of children admitted to the pediatric services of Istanbul University Istanbul Faculty of Medicine between May 2023 and October 2023. The sample size was determined based on literature findings (Boztepe and Abusfia, 2015), considering a type I error rate of 0.05, a test power of 0.91 (α= 0.05, 1-β= 0.95). The minimum sample size for each group was calculated as 66 (n=33). However, to mitigate the possibility of losing cases, a total sample size of 80 patients was determined, with 40 patients in each group. Therefore, 40 patients would constitute the open system catheter group, and 40 patients would form the closed system catheter group. The selection of the sample was carried out through simple randomization based on predefined criteria for grouping the children.
Randomization:
In the study, there are two groups: the study group using closed system peripheral catheters and the control group receiving the routine procedure of the clinic with open system peripheral catheters. Children meeting the inclusion criteria were assigned to groups through a randomization process.
Subsequently, whenever a child meeting the inclusion criteria presented to the pediatric service, a nurse working in the unit, other than the researcher, asked the child to randomly select a piece of paper from a bag. If the paper indicated "control group," the child was assigned to the control group; if it indicated "study group," the child was assigned to the study group.
This randomization method, utilizing a simple and practical approach with the use of paper lots from a bag, ensures that each eligible child has an equal chance of being assigned to either the control or study group. The process helps minimize bias and ensures a more balanced distribution of characteristics across the groups, contributing to the reliability of the study results.
Data Collection:
In the pediatric service where the research was conducted, peripheral venous access and care for children were carried out by nurses using an open system catheter. The control group in this study consisted of the open system catheter group.
Data collection was performed in 6 stages:
Stage: Before the data collection process, a pilot application was conducted with 10 children to assess the suitability of the forms used in the research. Final adjustments were made to the forms after the pilot application.
Stage: Children included in the sample (aged 6 and older) and their parents were informed about the research, and verbal and written consents (informed consent) were obtained.
Stage: Patients meeting the sample selection criteria were randomly and equally distributed into two groups using the randomization method (1st group: control group with open system peripheral catheter application (n=40), 2nd group: study group with closed system peripheral catheter application (n=40)). It was ensured that the parents of children in both groups were present.
Stage: Before the procedure, the researcher filled out the "Patient Identification Form" for all children in the groups.
Stage: According to the group to which the child belonged, the researcher applied the "Peripheral Catheter Insertion and Removal Protocol." The protocol included the following steps:
Hands were washed, and necessary materials (gloves, cotton, an appropriately sized catheter for the child, 0.5% chlorhexidine-containing 70% alcohol, transparent drape, venous valve, saline solution, syringe) were prepared.
The area for catheter insertion was selected (upper extremity veins). Using aseptic technique, the catheter was inserted using the appropriate method (gloves were worn, the catheter area was wiped three times with a solution of 2% chlorhexidine-containing 70% alcohol, and it was allowed to dry; the cleaned area was not touched after wiping).
After inserting the catheter, it was secured using a transparent drape for easy observation.
For children with open system peripheral catheters, a venous valve was attached after catheter insertion to reduce movement of the catheter.
Catheter dressing was changed if there was moisture, looseness, or noticeable contamination.
Stage: After the insertion of the peripheral venous catheter (PVC), children were monitored daily using the "Daily Monitoring Form" until 48 hours after removal.
Data Analysis:
The data obtained in the research were analyzed using the Statistical Package for Social Sciences (SPSS) 22.0 program. Normal distribution analysis was conducted, and it was determined that the data did not follow a normal distribution. Therefore, non-parametric tests were employed for the analyses.
For qualitative variables, frequency and percentage calculations were performed.
For quantitative variables, mean, standard deviation, and median tests were conducted.
Categorical variables were compared using the Chi-square test, while quantitative variables were compared using the Mann-Whitney U test.
A significance level of p\<0.05 was considered in the analyses. This means that statistically significant differences were considered when the p-value was below 0.05. This value represents the significance level used to determine differences between various groups in the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Closed System Peripheral Catheters
After the area where the catheter would be inserted was cleaned with an antiseptic solution and allowed to dry, a closed-system catheter was applied. Closed-system catheters are devices that allow access through needleless mechanisms, protecting the patient from accidental needle puncture injuries. They have mechanisms preventing blood leakage or pathogen entry.
Closed-system catheter
Closed-system catheters was applied
Control
After the area where the catheter would be inserted was cleaned with an antiseptic solution and allowed to dry, a catheter was applied.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Closed-system catheter
Closed-system catheters was applied
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having a catheter requirement for at least 72 hours,
* The catheter being inserted in the admitting service,
* Catheters not being inserted under emergency conditions,
* Absence of other catheters (central venous, arterial, PICC line, etc.),
* Body temperature not exceeding 38°C,
* Absence of skin issues in the catheter area,
* Not undergoing chemotherapy treatment,
* The catheter being inserted in the upper extremity,
* Willingness to voluntarily participate in the study.
Exclusion Criteria
* Having a catheter requirement of less than 72 hours,
* Peripheral catheters being inserted under emergency conditions,
* Presence of other catheters in the child (central venous, arterial, PICC line, etc.),
* Body temperature exceeding 38°C,
* Presence of skin issues in the area where the catheter will be inserted,
* Undergoing chemotherapy treatment,
* Unwillingness to voluntarily participate in the study.
1 Month
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tarsus University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Duygu Sonmez Duzkaya
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tarsus University
Mersin, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Amjad I, Murphy T, Nylander-Housholder L, Ranft A. A new approach to management of intravenous infiltration in pediatric patients: pathophysiology, classification, and treatment. J Infus Nurs. 2011 Jul-Aug;34(4):242-9. doi: 10.1097/NAN.0b013e31821da1b3.
Clark E, Giambra BK, Hingl J, Doellman D, Tofani B, Johnson N. Reducing risk of harm from extravasation: a 3-tiered evidence-based list of pediatric peripheral intravenous infusates. J Infus Nurs. 2013 Jan-Feb;36(1):37-45. doi: 10.1097/NAN.0b013e3182798844.
Corley A, Ullman AJ, Mihala G, Ray-Barruel G, Alexandrou E, Rickard CM. Peripheral intravenous catheter dressing and securement practice is associated with site complications and suboptimal dressing integrity: A secondary analysis of 40,637 catheters. Int J Nurs Stud. 2019 Dec;100:103409. doi: 10.1016/j.ijnurstu.2019.103409. Epub 2019 Aug 28.
Doellman D, Hadaway L, Bowe-Geddes LA, Franklin M, LeDonne J, Papke-O'Donnell L, Pettit J, Schulmeister L, Stranz M. Infiltration and extravasation: update on prevention and management. J Infus Nurs. 2009 Jul-Aug;32(4):203-11. doi: 10.1097/NAN.0b013e3181aac042.
Duncan M, Warden P, Bernatchez SF, Morse D, (2018), A bundled approach to decrease the rate of primary bloodstream infections related to peripheral intravenous catheters, J Assoc Vasc Access, 23(1), 15-22.
Arias-Fernandez L, Suerez-Mier B, Martinez-Ortega MD, Lana A. Incidence and risk factors of phlebitis associated to peripheral intravenous catheters. Enferm Clin. 2017 Mar-Apr;27(2):79-86. doi: 10.1016/j.enfcli.2016.07.008. Epub 2016 Sep 16. English, Spanish.
Gonzalez Lopez JL, Arribi Vilela A, Fernandez del Palacio E, Olivares Corral J, Benedicto Marti C, Herrera Portal P. Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters: a randomized study. J Hosp Infect. 2014 Feb;86(2):117-26. doi: 10.1016/j.jhin.2013.10.008. Epub 2013 Dec 1.
Gorski LA, Hadaway L, Hagle ME, Broadhurst D, Clare S, Kleidon T, Meyer BM, Nickel B, Rowley S, Sharpe E, Alexander M. Infusion Therapy Standards of Practice, 8th Edition. J Infus Nurs. 2021 Jan-Feb 01;44(1S Suppl 1):S1-S224. doi: 10.1097/NAN.0000000000000396. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1763831
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.